perioperative lung damage
Conditions
Interventions
group SPI:SPI-guided analgesia
standard practice:based on BP and HR
Sponsors
Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria ASA I-III status patients scheduled for abdominal surgery, patients aged >18 yrs, duration of operation >3h.;Inclusion criteria: Inclusion criteria ASA I-III status patients scheduled for abdominal surgery, patients aged >18 yrs, duration of operation >3h.;Inclusion criteria: Inclusion criteria ASA I-III status patients scheduled for abdominal surgery, patients aged >18 yrs, duration of operation >3h.;Inclusion criteria: Inclusion criteria ASA I-III status patients scheduled for abdominal surgery, patients aged >18 yrs, duration of operation >3h.;Inclusion criteria: Inclusion criteria ASA I-III status patients scheduled for abdominal surgery, patients aged >18 yrs, duration of operation >3h.
Exclusion criteria
Exclusion criteria: 1. Patients refuse to participate in experiment; 2. Patients with upper respiratory tract or pulmonary infections in recent 4 weeks; 3. Patients with significant atelectasis, pleural effusion and COPD; 4. Previous thoracic surgery or neurosurgery; 5. Major cardiovascular, pulmonary, renal, and hematological disorders; 6. body mass index(BMI)>30 kg/m2.;Exclusion criteria: 1. Patients refuse to participate in experiment; 2. Patients with upper respiratory tract or pulmonary infections in recent 4 weeks; 3. Patients with significant atelectasis, pleural effusion and COPD; 4. Previous thoracic surgery or neurosurgery; 5. Major cardiovascular, pulmonary, renal, and hematological disorders; 6. body mass index(BMI)>30 kg/m2.;Exclusion criteria: 1. Patients refuse to participate in experiment; 2. Patients with upper respiratory tract or pulmonary infections in recent 4 weeks; 3. Patients with significant atelectasis, pleural effusion and COPD; 4. Previous thoracic surgery or neurosurgery; 5. Major cardiovascular, pulmonary, renal, and hematological disorders; 6. body mass index(BMI)>30 kg/m2.;Exclusion criteria: 1. Patients refuse to participate in experiment; 2. Patients with upper respiratory tract or pulmonary infections in recent 4 weeks; 3. Patients with significant atelectasis, pleural effusion and COPD; 4. Previous thoracic surgery or neurosurgery; 5. Major cardiovascular, pulmonary, renal, and hematological disorders; 6. body mass index(BMI)>30 kg/m2.;Exclusion criteria: 1. Patients refuse to participate in experiment; 2. Patients with upper respiratory tract or pulmonary infections in recent 4 weeks; 3. Patients with significant atelectasis, pleural effusion and COPD; 4. Previous thoracic surgery or neurosurgery; 5. Major cardiovascular, pulmonary, renal, and hematological disorders; 6. body mass index(BMI)>30 kg/m2.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative pulmonary complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| pulmonary function;cardiovescular function;visual analogue scale;opioids requirements; | — |
Countries
China
Contacts
Public ContactXueyin Shi;Xueyin Shi;Xueyin Shi;Xueyin Shi;Xueyin Shi ;;;;
Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.;Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.;Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.;Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.;Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Outcome results
None listed